← All trials
NCT00414128
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2007
- Primary completion
- Jul 1, 2011
- Completion date
- Feb 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 140
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of CambridgeLead sponsor
- University of CambridgeOverall official - principal investigator
- University of BirminghamOverall official - principal investigator
- Aspreva PharmaceuticalsCollaborator
- Vifor Inc.Collaborator
- University of CambridgeReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.